who manufactures retatrutide Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide UK: New Triple-Agonist Weight

Muscle Preservation Focus Resistance training helps preserve muscle mass during weight loss

Within the same period, the dispensed prescriptions within the benefit to incident patients with a preexisting diagnosis of obesity without T2DM increased by 270% (4.0 to 14.6%), and 502% for patients with neither obesity nor T2DM (5.3 to 32.1%), and 515% for patients without any of the included diagnoses (4.2 to 25.7%) (see Table 9 in the Appendix)

These medicines work by mimicking the action of the naturally occurring hormone GLP-1, which stimulates insulin secretion, suppresses glucagon release, and slows gastric emptying

The company also holds an F rating with the BBB